Last updated on December 2019

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)


Brief description of study

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Detailed Study Description

Primary

To evaluate the long-term safety and tolerability of seladelpar

Secondary

To evaluate the long-term efficacy of seladelpar

Clinical Study Identifier: NCT03301506

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.